Publication | Open Access

The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth

InflammationThrombosisTranslational MedicineVascular DiseaseAngiogenesisMedicineImmunologyEndothelial DysfunctionPathologyTherapeutic EfficacyVascular BiologyNeovascularizationInjury-elicited Arterial InflammationNeointimal GrowthPharmacologyAtherosclerosis